News from us and our partners

Tags

Topics

0 results

News
28 March, 2018
Sofinnova Partners leads SafeHeal's €6 million Series A
News
28 March, 2018
Sofinnova Partners mène le tour de financement de série A de 6 millions d’euros de la société SafeHeal
News
6 March, 2018
Sofinnova Partners mène le tour de financement de série A de 4 M€ de la société Micropep Technologies
News
6 March, 2018
Sofinnova Partners leads Micropep Technologies €4M Series A financing round
News
25 January, 2018
Gecko Biomedical secures €6 million in funding under the Investments for the Future program (Programme d’investissements d’avenir, PIA), to industrialize and develop innovative solutions for tissue re
News
25 January, 2018
Gecko Biomedical obtient 6 millions d’euros de financement dans le cadre du Programme d’investissements d’avenir (PIA) pour l’industrialisation et ledéveloppement de solutions innovantes pour la Recon
News
5 January, 2018
Pixium Vision receives FDA approval to begin human clinical study of its PRIMA retinal implant in the US
News
19 December, 2017
Ecolab agrees to acquire minority ownership in finnish Metgen OY
News
11 December, 2017
Mainstay Medical Announces Positive Outcome of Interim Analysis
News
11 December, 2017
Hookipa Biotech Raises $60 million (€50 million) in an Oversubscribed Round C Financing
News
8 December, 2017
Highlife appoints Jose Calle Gordo as Chairman of the board
News
29 November, 2017
ProQR Receives Orphan Drug Designation from EMA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa
News
29 November, 2017
Maina Bhaman joins Sofinnova Partners as Partner
News
29 November, 2017
Maina Bhaman rejoint Sofinnova Partners en tant que Partner
News
15 November, 2017
Inotrem granted access to priority medicines scheme (PRIME) for its lead compound MOTREM™ in the treatment of septic shock.
News
15 November, 2017
Inotrem obtient le statut de médicament prioritaire (PRIME) pour sa molécule leader MOTREM™ dédiée au traitement du choc septique.

Sofinnova Partners leads SafeHeal's €6 million Series A

Sofinnova Partners mène le tour de financement de série A de 6 millions d’euros de la société SafeHeal

Sofinnova Partners mène le tour de financement de série A de 4 M€ de la société Micropep Technologies

Sofinnova Partners leads Micropep Technologies €4M Series A financing round

Gecko Biomedical secures €6 million in funding under the Investments for the Future program (Programme d’investissements d’avenir, PIA), to industrialize and develop innovative solutions for tissue re

Gecko Biomedical obtient 6 millions d’euros de financement dans le cadre du Programme d’investissements d’avenir (PIA) pour l’industrialisation et ledéveloppement de solutions innovantes pour la Recon

Pixium Vision receives FDA approval to begin human clinical study of its PRIMA retinal implant in the US

Ecolab agrees to acquire minority ownership in finnish Metgen OY

Mainstay Medical Announces Positive Outcome of Interim Analysis

Hookipa Biotech Raises $60 million (€50 million) in an Oversubscribed Round C Financing

Highlife appoints Jose Calle Gordo as Chairman of the board

ProQR Receives Orphan Drug Designation from EMA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa

Maina Bhaman joins Sofinnova Partners as Partner

Maina Bhaman rejoint Sofinnova Partners en tant que Partner

Inotrem granted access to priority medicines scheme (PRIME) for its lead compound MOTREM™ in the treatment of septic shock.

Inotrem obtient le statut de médicament prioritaire (PRIME) pour sa molécule leader MOTREM™ dédiée au traitement du choc septique.